{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:29:48Z","timestamp":1793413788955,"version":"4.5.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:00:00Z","timestamp":1634169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019492","name":"National Natural Science Foundation of China-China Academy of General Technology Joint Fund for Basic Research","doi-asserted-by":"publisher","award":["82071712, 81771656, 81501249, 81873857, 81701439"],"award-info":[{"award-number":["82071712, 81771656, 81501249, 81873857, 81701439"]}],"id":[{"id":"10.13039\/501100019492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["20181803"],"award-info":[{"award-number":["20181803"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["SHWSRS\uff082021)_099"],"award-info":[{"award-number":["SHWSRS\uff082021)_099"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To evaluate the efficiency and validity of cessation of cetrorelix on trigger day during gonadotropin releasing hormone antagonist (GnRH-ant)-controlled ovarian stimulation of\n                      <jats:italic>in vitro<\/jats:italic>\n                      fertilization (IVF) cycles.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective study, a total of 1271 patients undergoing initial IVF cycles following the GnRH-ant protocol were enrolled; 832 patients received cetrorelix on trigger day (Group A) and 439 patients ceased cetrorelix on trigger day (Group B). We compared demographic characteristics, embryological and clinical outcomes between the two groups. A Poisson regression model was used to identify factors that significantly affected embryological outcomes. Patients were further divided into subgroups according to anti-Mullerian hormone (AMH) and age, to assess associations between ceasing cetrorelix on trigger day and embryological outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There was a significant improvement on embryological outcomes in patients who ceased cetrorelix on trigger day, and there were no significant differences in clinical outcomes or preovulation rates between the two groups. Furthermore, for patients with 1.1 \u2264 AMH \u2264 4.7 ng\/ml, all embryological outcomes were significantly higher in Group B compared with Group A. For patients with AMH &amp;gt; 4.7 ng\/ml, the number of oocytes retrieved, fertilization rate (2PN) of IVF cycles and proportion of day 3 good quality embryos were all significantly higher in Group B. For patients with age &amp;lt; 35 years, all the embryological outcomes, besides the number of available embryos, were significantly higher in Group B than in Group A. There were no differences in embryological outcomes between the two groups when patients were stratified based on age &amp;gt; 35 years or AMH &amp;lt; 1.1 ng\/ml.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GnRH-ant protocol with cessation of cetrorelix on trigger day improved embryological outcomes for young patients or patients with sufficient ovarian reserve, and was effective at preventing preovulation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2021.758896","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T03:49:16Z","timestamp":1634183356000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["GnRH Antagonist Protocol With Cessation of Cetrorelix on Trigger Day Improves Embryological Outcomes for Patients With Sufficient Ovarian Reserve"],"prefix":"10.3389","volume":"12","author":[{"given":"Huihui","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bufang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06797-6","article-title":"Gonadotropin-Releasing-Hormone-Receptor Antagonists","volume":"358","author":"Huirne","year":"2001","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/humupd\/dmr004","article-title":"GnRH Antagonists are Safer Than Agonists: An Update of a Cochrane Review","volume":"17","author":"Al-Inany","year":"2011","journal-title":"Hum Reprod Update"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH Antagonist Versus Long Agonist Protocols in IVF: A Systematic Review and Meta-Analysis Accounting for Patient Type","volume":"23","author":"Lambalk","year":"2017","journal-title":"Hum Reprod Update"},{"key":"B4","doi-asserted-by":"publisher","first-page":"39912","DOI":"10.1038\/srep39912","article-title":"Increased Uterine NK Cell Numbers and Perforin Expression During the Implantation Phase in IVF Cycles With GnRH Antagonist Protocol","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey119","article-title":"Increased AIF-1-Mediated TNF-Alpha Expression During Implantation Phase in IVF Cycles With GnRH Antagonist Protocol","volume":"33","author":"Xu","year":"2018","journal-title":"Hum Reprod"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dml004","article-title":"Endometrial Receptivity Markers, the Journey to Successful Embryo Implantation","volume":"12","author":"Achache","year":"2006","journal-title":"Hum Reprod Update"},{"key":"B7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1749-6632.2001.tb03789.x","article-title":"Gonadotropin-Releasing Hormone Antagonists Implications for Oocyte Quality and Uterine Receptivity","volume":"943","author":"Gordon","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dem270","article-title":"Are GnRH Antagonists Comparable to Agonists for Use in IVF","volume":"22","author":"Huirne","year":"2007","journal-title":"Hum Reprod"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-7-103","article-title":"Impact of GnRH Analogues on Oocyte\/Embryo Quality and Embryo Development in In Vitro Fertilization\/Intracytoplasmic Sperm Injection Cycles: A Case Control Study","volume":"7","author":"Murber","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705334","article-title":"Transfer of Fresh Versus Frozen Embryos in Ovulatory Women","volume":"378","author":"Shi","year":"2018","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-006-9054-0","article-title":"Is a Lower Dose of Cetrorelix Acetate Effective for Prevention of LH Surge During Controlled Ovarian Hyperstimulation","volume":"23","author":"Chen","year":"2006","journal-title":"J Assist Reprod Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-013-2806-z","article-title":"Effect of a Low Dose of Gonadotropin Releasing Hormone Antagonist on In Vitro Fertilization Outcomes","volume":"288","author":"Kerimoglu","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0154123","DOI":"10.1371\/journal.pone.0154123","article-title":"A Patient Friendly Corifollitropin Alfa Protocol Without Routine Pituitary Suppression in Normal Responders","volume":"11","author":"Wang","year":"2016","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00767","article-title":"Flexible Low-Dose GnRH Antagonist Protocol Is Effective in Patients With Sufficient Ovarian Reserve in IVF","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2009.24.2.262","article-title":"Cessation of Gonadotropin-Releasing Hormone Antagonist on Triggering Day: An Alternative Method for Flexible Multiple-Dose Protocol","volume":"24","author":"Chang","year":"2009","journal-title":"J Korean Med Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.5653\/cerm.2013.40.2.83","article-title":"Cessation of Gonadotropin-Releasing Hormone Antagonist on Triggering Day in Flexible Multiple-Dose Protocol: A Randomized Controlled Study","volume":"40","author":"Chang","year":"2013","journal-title":"Clin Exp Reprod Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/13.9.2392","article-title":"Single and Multiple Dose Pharmacokinetics and Pharmacodynamics of the Gonadotrophin-Releasing Hormone Antagonist Cetrorelix in Healthy Female Volunteers","volume":"13","author":"Duijkers","year":"1998","journal-title":"Hum Reprod"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/s1472-6483(10)61611-2","article-title":"Clomiphene-Induced LH Surges and Cetrorelix","volume":"5","author":"Engel","year":"2002","journal-title":"Reprod BioMed Online"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00327","article-title":"Impact of Maternal Age on Oocyte and Embryo Competence","volume":"9","author":"Cimadomo","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-015-0595-y","article-title":"Diminished Ovarian Reserve, Premature Ovarian Failure, Poor Ovarian Responder\u2013a Plea for Universal Definitions","volume":"32","author":"Cohen","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1393","article-title":"Can Anti-Mullerian Hormone Predict the Diagnosis of Polycystic Ovary Syndrome? A Systematic Review and Meta-Analysis of Extracted Data","volume":"98","author":"Iliodromiti","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/s1472-6483(10)60385-9","article-title":"Effect of Increased Body Mass Index on Oocyte and Embryo Quality in IVF Patients","volume":"15","author":"Metwally","year":"2007","journal-title":"Reprod BioMed Online"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001750.pub4","article-title":"Gonadotrophin-Releasing Hormone Antagonists for Assisted Reproductive Technology","volume":"4","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1743-1050-5-4","article-title":"Estrogen Level Monitoring in Artificial Frozen-Thawed Embryo Transfer Cycles Using Step-Up Regime Without Pituitary Suppression: Is it Necessary","volume":"5","author":"Niu","year":"2008","journal-title":"J Exp Clin Assist Reprod"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3109\/19396368.2014.967368","article-title":"The Effects of Fertilization Mode, Embryo Morphology at Day 3, and Female Age on Blastocyst Formation and the Clinical Outcomes","volume":"61","author":"Yin","year":"2015","journal-title":"Syst Biol Reprod Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/13.12.3434","article-title":"A Prospective Randomized Trial of Blastocyst Culture and Transfer in In-Vitro Fertilization","volume":"13","author":"Gardner","year":"1998","journal-title":"Hum Reprod"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.29252\/ijrm.14.9.557","article-title":"GnRH Agonist Trigger Versus hCG Trigger in GnRH Antagonist in IVF\/ICSI Cycles: A Review Article","volume":"14","author":"Alyasin","year":"2016","journal-title":"Int J Reprod Biomed"},{"key":"B28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/biolre\/ioy082","article-title":"Adverse Effect of Prematurely Elevated Progesterone in In Vitro Fertilization Cycles: A Literature Review","volume":"99","author":"Evans","year":"2018","journal-title":"Biol Reprod"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-018-4793-6","article-title":"Beta Endorphin in Serum and Follicular Fluid of PCOS- and non-PCOS Women","volume":"298","author":"Jaschke","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(99)00524-5","article-title":"Prospective, Randomized, Controlled Study of In Vitro Fertilization-Embryo Transfer With a Single Dose of a Luteinizing Hormone-Releasing Hormone (LH-RH) Antagonist (Cetrorelix) or a Depot Formula of an LH-RH Agonist (Triptorelin)","volume":"73","author":"Olivennes","year":"2000","journal-title":"Fertil Steril"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/s1472-6483(10)62163-3","article-title":"Safety and Efficacy of a 3 Mg Dose of the GnRH Antagonist Cetrorelix in Preventing Premature LH Surges: Report of Two Large Multicentre, Multinational, Phase IIIb Clinical Experiences","volume":"6","author":"Olivennes","year":"2003","journal-title":"Reprod BioMed Online"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/humupd\/dmx029","article-title":"The Epidermal Growth Factor Network: Role in Oocyte Growth, Maturation and Developmental Competence","volume":"24","author":"Richani","year":"2018","journal-title":"Hum Reprod Update"},{"key":"B33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/humupd\/dml062","article-title":"Molecular Mechanisms of Ovulation: Co-Ordination Through the Cumulus Complex","volume":"13","author":"Russell","year":"2007","journal-title":"Hum Reprod Update"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/17.2.517-a","article-title":"The Potential Value of Mid-Follicular Phase LH","volume":"17","author":"Filicori","year":"2002","journal-title":"Hum Reprod"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh601","article-title":"Dose-Finding Study of Daily GnRH Antagonist for the Prevention of Premature LH Surges in IVF\/ICSI Patients: Optimal Changes in LH and Progesterone for Clinical Pregnancy","volume":"20","author":"Huirne","year":"2005","journal-title":"Hum Reprod"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.10.022","article-title":"GnRH Agonist Versus GnRH Antagonist in Ovarian Stimulation: The Role of Endometrial Receptivity","volume":"90","author":"Orvieto","year":"2008","journal-title":"Fertil Steril"},{"key":"B37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.tem.2004.01.009","article-title":"Reproductive Biology and IVF: Ovarian Stimulation and Endometrial Receptivity","volume":"15","author":"Devroey","year":"2004","journal-title":"Trends Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201400145","article-title":"Effects of GnRH Antagonist on Endometrial Protein Profiles in the Window of Implantation","volume":"14","author":"Meng","year":"2014","journal-title":"Proteomics"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2008.00737.x","article-title":"Gonadotropin-Releasing Hormone (GnRH)-I Regulation of Interleukin (IL)-1b and IL-1 Receptor Antagonist Expression in Cultured Human Endometrial Stromal Cells","volume":"34","author":"Raga","year":"2008","journal-title":"J Obstet Gynaecol Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.gyobfe.2012.11.003","article-title":"Impact of Polycystic Ovary Syndrome on Oocyte and Embryo Quality","volume":"41","author":"Sermondade","year":"2013","journal-title":"Gynecol Obstet Fertil"},{"key":"B41","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1055\/s-2008-1042958","article-title":"Oocyte Quality in Adult Polycystic Ovary Syndrome","volume":"26","author":"Patel","year":"2008","journal-title":"Semin Reprod Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep404","article-title":"A Reduced Size of the Ovarian Follicle Pool Is Associated With an Increased Risk of a Trisomic Pregnancy in IVF-Treated Women","volume":"25","author":"Haadsma","year":"2010","journal-title":"Hum Reprod"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dei270","article-title":"Mullerian Inhibiting Substance Levels at the Time of HCG Administration in IVF Cycles Predict Both Ovarian Reserve and Embryo Morphology","volume":"21","author":"Silberstein","year":"2006","journal-title":"Hum Reprod"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.07.001","article-title":"Serum Antimullerian Hormone Levels are Independently Related to Miscarriage Rates After In Vitro Fertilization-Embryo Transfer","volume":"108","author":"Tarasconi","year":"2017","journal-title":"Fertil Steril"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12368","article-title":"Coenzyme Q10 Restores Oocyte Mitochondrial Function and Fertility During Reproductive Aging","volume":"14","author":"Ben-Meir","year":"2015","journal-title":"Aging Cell"},{"key":"B46","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.fertnstert.2013.11.004","article-title":"The Nature of Aneuploidy With Increasing Age of the Female Partner: A Review of 15,169 Consecutive Trophectoderm Biopsies Evaluated With Comprehensive Chromosomal Screening","volume":"101","author":"Franasiak","year":"2014","journal-title":"Fertil Steril"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.01.013","article-title":"Aging and the Environment Affect Gamete and Embryo Potential: Can We Intervene","volume":"105","author":"Meldrum","year":"2016","journal-title":"Fertil Steril"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.758896\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T03:49:20Z","timestamp":1634183360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.758896\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,14]]},"references-count":47,"alternative-id":["10.3389\/fendo.2021.758896"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.758896","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,14]]},"article-number":"758896"}}